Journal article icon

Journal article : Review

Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation

Abstract:
Psychomotor retardation, defined as generalized slowing of movement and speech, is a feature of several neurological and psychiatric disorders. In this review, we discuss the hypothesis that reduced striatal dopaminergic transmission is a transdiagnostic substrate for psychomotor retardation underlying the motor features of conditions such as Parkinson’s disease, drug-induced parkinsonism, neuroleptic malignant syndrome, catatonia and depression. We examine the evidence across clinical, epidemiological, neuroimaging, laboratory and therapeutic studies. Parkinsonian disorders share slowed movement and a reduction in verbal output with catatonia and depression. Bradyphrenia, slowed cognitive processing, also occurs in Parkinson’s disease and depression. In addition, there are close epidemiological relationships between depression and Parkinson’s disease, and between catatonia and neuroleptic malignant syndrome. Neuroimaging studies also generally support the association of psychomotor retardation with reduced dopaminergic transmission, particularly in the dorsal striatum. CSF measurement of homovanillic acid (a dopamine catabolite) yields inconsistent results and is non-specific. Parkinson’s disease and catatonia generally respond well to dopaminergic medication. In contrast, dopamine antagonists can induce both parkinsonism and catatonia. Our review is limited by the variability in measurement of psychomotor retardation and difficulty distinguishing between cognitive and motor slowing. It is also likely that other neurotransmitters, such as GABA and serotonin, play an important role in psychomotor speed. It is possible that dopaminergic deficits in psychiatric disorders represent functional disruptions, in contrast to the structural damage to the substantia nigra in Parkinson’s disease. We propose further research be conducted into the effects of levodopa and dopamine agonists in depression with psychomotor retardation. Alternative neuroimaging methods such as PET sequences with shorter imaging protocols and neuromelanin-MRI should also be explored.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Role:
Author
ORCID:
0000-0003-4490-9219


More from this funder
Funder identifier:
https://ror.org/029chgv08
More from this funder
Funder identifier:
https://ror.org/05mnth393


Publisher:
Oxford University Press
Journal:
Brain More from this journal
Volume:
149
Issue:
1
Pages:
18-36
Publication date:
2025-09-12
Acceptance date:
2025-08-14
DOI:
EISSN:
1460-2156
ISSN:
0006-8950


Language:
English
Keywords:
Subtype:
Review
Pubs id:
2289812
UUID:
uuid_1bd8b6a2-0aee-4ebe-9ff1-8a4c56407a2b
Local pid:
pubs:2289812
Source identifiers:
3645460
Deposit date:
2026-01-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP